Delivery Order SPE2DB20D3505-SPE2DB25FYCSJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ramelteon 8 mg tablets (100-count units) with a contract ceiling value of $3,606.44. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The ultimate completion date is August 14, 2025, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ramelteon 8 mg tablets in unit-dose packaging (50-count) valued at $2,315.08. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $3,856.49 to AmerisourceBergen Drug Corp for the supply of Ramelteon 8 mg tablets (30-count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply transaction under AmerisourceBergen's...
- This delivery order, valued at $2,751.58, was awarded on September 8, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of Ramelteon 8 mg tablets (30-count packages). The contract represents a non-competitive, firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Ramelteon 8 mg tablets (30-count units) with a ceiling value of $2,269.62. This firm fixed price contract, with an ultimate completion date of June 2, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively procured without set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $2,039.56 to AmerisourceBergen Drug Corp for 30 tablets of Ramelteon 8 mg, a medication used to treat insomnia. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ramelteon 8 mg tablets in unit dose packaging (50-count) with a contract ceiling value of $7,347.27. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The ultimate completion date is set for September 26, 2025, and the product will be delivered to AmerisourceBergen's location in Conshohocken,...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,177,965 units of the sleep medication Ramelteon 8 mg Tablet 30s. The $1,415.04 contract has a performance period through May 8, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,122 to Amerisourcebergen Drug Corporation. The order is for 30 packages of 8mg Ramelteon tablets to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 7, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform as the prime contractor under this order placed against an existing DLA contract vehicle. No set aside designation or...
- The Defense Logistics Agency awarded a delivery order valued at $394.39 to Amerisourcebergen Drug Corporation for the supply of 4561543359 Ramelteon 8 mg tablets. As the prime contractor, Amerisourcebergen will deliver 100 units of the specified pharmaceutical product to a facility in Conshohocken, Pennsylvania under a firm fixed price contract executed on July 19, 2023 for completion by July 20, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FYCSJDelivery Order
The Defense Logistics Agency awarded a $1,557.76 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Ramelteon 8 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 23, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected for this delivery order based on its established capability to meet federal medical procurement requirements. The company serves as a critical vendor for military and veteran healthcare systems through its comprehensive portfolio of pharmaceutical products and medical supplies. This award exemplifies the company's ongoing role in supporting the Defense Health Agency and other government healthcare entities through its prime vendor contract, which enables flexible procurement of specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/22/25 |